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Introduction
Vancomycin-resistant Enterococci (VRE) is one of the
most important hospital pathogens.
Objectives
The aim of the study was to evaluate the VRE coloniza-
tion in patients hospitalized at the Hematology Intensive
Care Unit and associated risk factors.
Methods
Prospective cohort study involved 70 patients hospitalized
at the Intensive Care Unit (ICU), Clinic for Hematology,
during three months. Demographic data and data risk fac-
tors for VRE colonization during present and previous
hospitalization (within 6 months) were recorded for each
patient using the questionnaire. Feces or rectal swab was
collected for culture from patients on admission and at
discharge in case when VRE was not isolated on admis-
sion. The Enterococci were isolated by standard microbio-
logical methods. Isolate sensitivity was tested by disk-
diffusion test using the 30μg/ml (BBL) Vancomycin plates
according to CLSI standard.
Results
Upon admission, 7% of patients were already colonized
with VRE. The rate of VRE colonization during present
hospitalization was 41.5%. Univariate logistic regression
demonstrated statistical significant differences of acute
myeloid leukemia (AML) diagnosis (RR=3.1; 95%CI
1.1-8.6; p=0.03), length of present stay (RR=1.1; 95%CI
1.1-1.2; p=0.002), use of aminoglycosides (RR=3.9; 95%CI
1.1-13.1; p=0.03), and pip/tazobactam (RR=4.7; 95%CI
1.6-13.9; p=0.005) in present hospitalization, duration of
use of carbapenem (RR=1.2; 95%CI 1.1-1.3; p=0.05) and
pip/tazobactam (RR=1.4; 95%CI 1.3-1.7; p=0.006) in
present hospitalization between the VRE-colonized and
non-colonized patients. AML, use of carbapenem in pre-
vious hospitalization and duration of use of piperacillin/
tazobactam in present hospitalization were independent
risk factors of VRE-colonized patients according to multi-
variate logistic regression.
Conclusion
VRE colonization rate was high among patients admitted
to hematology ICU. Rational use of antibiotics and an
active surveillance may be helpful preventive measures
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